Treatment of patients with neuropathy and anti‐MAG IgM M‐proteins
- 1 July 1988
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 24 (1), 93-97
- https://doi.org/10.1002/ana.410240118
Abstract
Five patients with neuropathy and IgM M‐proteins that reacted with myelin‐associated glycoprotein (MAG) were treated for 10 to 20 months with cytostatic agents. In 2 patients, a Decemberrease in serum M‐protein and in anti‐MAG IgM levels coincided with a progressive improvement of neuropathy. No clinical improvement and no Decemberrease of anti‐MAG IgM were observed in the other patients. The close relationship between the Decemberrease of anti‐MAG, M‐proteins and clinical improvement in these patients supports the pathogenetic role of the M‐protein in the neuropathy.This publication has 14 references indexed in Scilit:
- Peripheral neuropathy in macroglobulinemiaNeurology, 1987
- Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti‐MAG IgM M‐proteinNeurology, 1987
- Monoclonal gammopathy and neuropathyNeurology, 1986
- Immunofluorescence study of patients with neuropathy and IgM M proteinsAnnals of Neurology, 1985
- Plasma exchange treatment of peripheral neuropathy associated with plasma cell dyscrasia.Journal of Neurology, Neurosurgery & Psychiatry, 1984
- Demyelinating polyneuropathy associated with monoclonal IgM-paraproteinaemiaJournal of the Neurological Sciences, 1984
- Anti‐MAG IgM antibodies in patients with neuropathy and IgM M proteinsNeurology, 1983
- Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: A Morphological studyAnnals of Neurology, 1983
- Plasma-Cell Dyscrasia and Peripheral Neuropathy with a Monoclonal Antibody to Peripheral-Nerve MyelinNew England Journal of Medicine, 1980
- Polyneuropathies of Undetermined CauseActa Neurologica Scandinavica, 1970